DexCom, Inc.
DXCM
Xếp hạng trong cổ phiếu
#755
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Giá cổ phiếu
$86.01
Vốn hóa thị trường
$32.45B
Thay đổi (1 ngày)
-0.04%
Thay đổi (1 năm)
29.14%
Quốc gia
US
Giao dịch DexCom, Inc. (DXCM)
Danh mục
Healthcare
EPS của DexCom, Inc. (DXCM)
EPS tính đến June 2026 TTM: $2.59
Theo các báo cáo tài chính mới nhất và giá cổ phiếu của DexCom, Inc., EPS hiện tại của công ty (TTM) là $2.59. Vào cuối năm 2024, công ty có EPS là $1.46, tăng so với EPS năm 2023 là $1.44.
Lịch sử EPS của DexCom, Inc. từ 2000 đến 2026
EPS vào cuối mỗi năm
| Năm | EPS | Thay đổi |
|---|---|---|
| 2026 (TTM) | $2.59 | 21.03% |
| 2025 | $2.14 | 46.58% |
| 2024 | $1.46 | 1.39% |
| 2023 | $1.44 | 63.64% |
| 2022 | $0.88 | 57.14% |
| 2021 | $0.56 | -57.25% |
| 2020 | $1.31 | 367.86% |
| 2019 | $0.28 | -177.78% |
| 2018 | $-0.36 | 140.00% |
| 2017 | $-0.15 | -25.00% |
| 2016 | $-0.20 | 11.11% |
| 2015 | $-0.18 | 141.61% |
| 2014 | $-0.07 | -25.50% |
| 2013 | $-0.10 | -50.00% |
| 2012 | $-0.20 | 17.65% |
| 2011 | $-0.17 | -29.17% |
| 2010 | $-0.24 | -20.00% |
| 2009 | $-0.30 | -36.17% |
| 2008 | $-0.47 | 14.63% |
| 2007 | $-0.41 | -4.65% |
| 2006 | $-0.43 | 4.88% |
| 2005 | $-0.41 | -73.20% |
| 2004 | $-1.53 | 34.21% |
| 2003 | $-1.14 | 21.28% |
| 2002 | $-0.94 | 13.25% |
| 2001 | $-0.83 | 45.61% |
| 2000 | $-0.57 | 0.00% |
EPS cho các công ty hoặc đối thủ cạnh tranh tương tự
| Công ty | EPS | Chênh lệch EPS | Quốc gia |
|---|---|---|---|
| $3.11 | 20.08% |
US
|
|
| $3.59 | 38.61% |
IE
|
|
| $9.73 | 275.68% |
US
|
|
| $2.48 | -4.25% |
US
|
|
| - | - |
DE
|
